The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I trial of the human double minute 2 (HDM2) inhibitor MK-8242 in patients (pts) with advanced solid tumors.
 
Andrew J. Wagner
No Relationships to Disclose
 
Udai Banerji
No Relationships to Disclose
 
Amit Mahipal
No Relationships to Disclose
 
Neeta Somaiah
No Relationships to Disclose
 
Heather Anne Hirsch
Employment - Merck
 
Craig Fancourt
Employment - Merck
Stock and Other Ownership Interests - Merck
Patents, Royalties, Other Intellectual Property - Merck (Inst)
 
Amy Levonas
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Raymond Lam
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Amy Meister
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Ramon Karmel Kemp
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Clayton Knox
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Shelonitda Rose
Employment - Merck
Stock and Other Ownership Interests - Merck
 
David S. Hong
Consulting or Advisory Role - Eisai; Janssen
Research Funding - Amgen (Inst); AstraZeneca (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Isis Pharmaceuticals (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst)